Skip to main content
SpringerLink
Log in

Hib conjugate vaccine good value for money worldwide

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Global Alliance for Vaccines and Immunization

References

  1. Griffiths UK, et al. Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants. Journal of Pediatrics 163: S50-S59, No. 1, Jul 2013. Available from: URL: http://dx.doi.org/10.1016/j.jpeds.2013.03.031.

    Article  PubMed  Google Scholar 

  2. Clark AD, et al. Impact and Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccination in India. Journal of Pediatrics 163: S60-72, No. 1, Jul 2013. Available from: URL: http://dx.doi.org/10.1016/j.jpeds.2013.03.032.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hib conjugate vaccine good value for money worldwide. PharmacoEcon Outcomes News 682, 6 (2013). https://doi.org/10.1007/s40274-013-0539-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0539-7

Search

Navigation